2025
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases
View on PubMed
Evidence & Outputs
Research & Publications
Peer-reviewed publications by Dr. Dora E. Corzo-León in medical mycology, invasive fungal disease and anti-infective development — the evidence base behind our advisory work.
Selected peer-reviewed publications
A selection of Dr. Corzo-León's recent peer-reviewed work in invasive fungal disease, antifungal therapy and diagnostics. Each entry links to its record on PubMed.
2026
Pulmonary fungal infections in the age of biologics and climate change
Current Opinion in Pulmonary Medicine
View on PubMed 2025
Characterization of the Spatiotemporal Localization of a Pan-Mucorales-Specific Antigen During Germination and Immunohistochemistry
The Journal of Infectious Diseases
View on PubMed 2026
Cutaneous mucormycosis confirmed using a Mucorales-specific monoclonal antibody: a case study
Frontiers in Medicine
View on PubMed 2025
Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease
The Brazilian Journal of Infectious Diseases
View on PubMed 2025
Access to diagnostic testing for invasive fungal diseases and other opportunistic infections in Mexican health care centers caring for patients living with HIV
BMC Health Services Research
View on PubMed 2025
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
The Brazilian Journal of Infectious Diseases
View on PubMed 2024
Bacterial co-infections in mucormycosis in severely ill populations: an overlooked and complex challenge
Access Microbiology
View on PubMed 2024
Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era
Mycoses
View on PubMedNeed an evidence-led advisory partner?
We combine deep clinical expertise with academic rigour to support pharmaceutical development and medical affairs.
Consulting Enquiries